Display search results for ** instead (41 products)

Showing 21-30 of 41

23 Jun 2017  |  Global

Blockchain Technology in Global Healthcare, 2017–2025

Healthcare Industry Assesses Blockchain Potential to Optimize Healthcare Workflows and Improve Outcome-based Care Delivery Models

Blockchain technology, with its ubiquitous security infrastructure for seamless health data exchange, holds potential to eliminate the burden and cost of health data reconciliation and facilitate interoperability. Emerging blockchain systems promise to unlock new economic advantages by disintermediating high-cost gatekeepers and automating transact...

USD 4,950.00

USD 3,712.50 save 25 %

13 Jun 2017  |  Global

Global Healthcare Data Analytics Companies-To-Action, 2017

Diverse Data Analytics Offerings Together have Potential to Change Industry Paradigms

Healthcare data analytics refers to information technology (IT) solutions and services that mine structured and unstructured digital content generated by healthcare industry stakeholders with the goal of achieving a pre-defined outcome. The healthcare industry is experiencing a redefinition of “value” through the changing expectations of care ...

USD 3,000.00

USD 2,250.00 save 25 %

16 Mar 2017  |  Global

Frost & Sullivan’s Top Emerging Markets List 2017

Growth, Innovation and Leadership (GIL) Index for Emerging Markets

The opening up of emerging markets to global capital, technology, and talent over the past two decades has fundamentally changed their economic and business environment. Rapid emerging market economic growth has helped lift millions out of poverty and expand the middle class, creating new markets for consumer products and services. In addition a la...

USD 1,500.00

USD 1,125.00 save 25 %

12 Jan 2017  |  Global

Future of Behavioral Healthcare Paradigms, Forecast to 2022

Digital Solutions to Address Challenges in Patient Engagement and Support

The annual global cost of mental illnesses is set to rise to a whopping $6 trillion in 2030, from $2.5 trillion in 2010. Furthermore, the global treatment gap in 2004 for disorders such as depression and anxiety was more than 50% (half of the patients went untreated). Unfortunately, the situation has still not changed significantly. A growing body...

USD 4,950.00

USD 3,712.50 save 25 %

16 Nov 2016  |  Global

Innovations in the Global Orthopedic Devices Industry

Assessing the Innovations in Orthopedic Devices and Procedure Improvement Solutions that are set to Transform the Industry

The insight analyzes the innovations expected to play a major role in shaping the global orthopedic devices industry over the next few years. The demand for patient-specific implantation/surgeries is rising, along with the demand for better procedural efficiencies. This is becoming a driver for the emergence of new technologies. Therapies and proce...

USD 1,500.00

USD 1,125.00 save 25 %

08 Sep 2016  |  Global

Growth Opportunities for Healthcare Big Data—An Analysis of Global Case Studies

Big Data Initiatives Targeted at Health Prediction and Precision

The healthcare industry has been a laggard in Big Data adoption as compared to other verticals and continues to battle challenges around interoperability, budget constraints, and insufficient strategic planning and change management. However, the intent to leverage the power of Big Data is evident across all industry stakeholders, including governm...

USD 1,500.00

USD 1,125.00 save 25 %

This Vital Signs issue discusses the clinical diagnostics laboratory tests payment system, approval of a Zika test kit, the impact on innovation of mergers in the pharma/biotech industry, and national healthcare expenditure projections through 2025.

USD 600.00

USD 450.00 save 25 %

This Vital Signs issue discusses Luminex's acquisition of Nanosphere, Medicare's changing approach to paying doctors, Orig3N's partnership with the San Francisco 49ers for collection of blood samples for research, and FDA's halt of Juno Therapeuticss cell therapy trial which left three dead.

USD 450.00

USD 337.50 save 25 %

This Vital Signs issue discusses Sinocare's acquisition of PTS Diagnostics, biosimilar drug pricing, Americans' usage of prescription pain killers, and Takara Bio's acquistion of Wafergen Bio-systems.

USD 450.00

USD 337.50 save 25 %

30 Jun 2016  |  Global

Global Immunoglobulin Therapeutics Market

 

Immunoglobulin (Ig) therapies are among the oldest therapeutic moieties employed in a broad range of pathological conditions. Immunoglobulin G (IgG) holds the highest share (44%) in the global blood plasma market, with a revenue of $9.24 billion. Currently, the global Ig market is dominated by three major companies, holding about 85% of the total m...

USD 1,500.00

USD 1,125.00 save 25 %

Showing 21-30 of 41